Eversept Partners’s Medicines Co MDCO Stock Holding History

Eversept Partners’s Portfolio MDCO Stock Details MDCO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-114,358	Closed	-$9.71M	–	86
2019 Q4	$9.71M	Buy	+114,358	New	+$7.63M	1.72%	16
2019 Q3	–	Sell	-57,200	Closed	-$2.09M	–	73
2019 Q2	$2.09M	Sell	57,200 -19,000	-25%	-$620K	0.58%	36
2019 Q1	$2.13M	Buy	+76,200	New	+$1.8M	0.62%	30
2018 Q4	–	Sell	-16,717	Closed	-$500K	–	76
2018 Q3	$500K	Sell	16,717 -22,600	-57%	-$851K	0.22%	51
2018 Q2	$1.44M	Hold	39,317	–	–	0.66%	30
2018 Q1	$1.3M	Buy	+39,317	New	+$1.23M	0.6%	32

Other funds holding MDCO

Glenmede Trust Philadelphia, Pennsylvania $22.7B AUM

Eversept Partners's MDCO Position: Q1 2020 in Review

Eversept Partners sold out of Medicines Co (MDCO) in Q1 2020, closing a stake of 114,358 shares — an estimated $9.71M sold.

Eversept Partners first reported a position in MDCO in Q1 2018 and held it in 6 quarters. The position peaked at $9.71M in Q4 2019. 1 fund tracked by Wall St. Rank holds MDCO as of Q1 2020.

Eversept Partners reported no remaining Medicines Co position as of Q1 2020 after selling out during the quarter.
Eversept Partners sold 114,358 Medicines Co shares in Q1 2020, an estimated $9.71M.
Eversept Partners first reported a position in Medicines Co in Q1 2018 and held it in 6 quarters.
Eversept Partners's Medicines Co position peaked at $9.71M in Q4 2019.
1 fund tracked by Wall St. Rank held Medicines Co as of Q1 2020.

Based on Eversept Partners's 13F filing for Q1 2020, filed 13 May 2020.